Thomas Savides, MD
Gastroenterology · San Diego, CANPI 1588649081
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,220 of the $21,552 with a category attached, or 61.3%. 13 manufacturers reported payments, led by Wilson Cook Medical Incorporated at 45.7% of the total.
Across 55 payments — averaging $391.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Wilson Cook Medical Incorporated$10K
- Cook Incorporated$6K
- Boston Scientific$4K
- Cook Medical LLC$921
- Fujifilm Healthcare Americas Corporation$298
- Conmed Corporation$215
- plus $293 from 7 others
What the payments were for
- Consulting fees$5,65026%
- Speaking & faculty fees$13,22061%
- Travel & lodging$400%
- Food & beverage$2,64312%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Wilson Cook Medical Incorporated | 2 | $9,845 |
| Cook Incorporated | 3 | $5,650 |
| Boston Scientific | 14 | $4,330 |
| Cook Medical LLC | 16 | $921 |
| Fujifilm Healthcare Americas Corporation | 2 | $298 |
| Conmed Corporation | 4 | $215 |
| Steris Corporation | 5 | $90 |
| Baxter Healthcare | 2 | $49 |
| Olympus America Inc. | 2 | $41 |
| Medtronic | 2 | $36 |
| Ambu Inc. | 1 | $30 |
| Apollo Endosurgery US Inc | 1 | $30 |
| ERBE USA Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FUSION$7,910
- Hemospray$3,705
- AXIOS$3,663
- Cook Medical Fusion$2,500
- ECHOTIP INSIGHT$1,695
- FUJIFILM$298
- GENERAL - THERAPIES$114
- GENERAL METAL STENTS GI$108
How this compares
$21,552 in reported general payments places this provider in the 85th percentile of 1,885 gastroenterology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PertzyeLipase/Protease/Amylase | 12 | $68,504 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 178 | $11,818 |
| Ursodiol | 31 | $2,277 |
| Dicyclomine Hcl | 19 | $784 |
| Omeprazole | 70 | $650 |
| Esomeprazole Magnesium | 13 | $649 |
| Fluconazole | 12 | $299 |
| Pantoprazole Sodium | 23 | $233 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in San Diego
- William SandbornSan Diego$340K
- David KunkelSan Diego$287K
- Naveen GaraSan Diego$178K
- Bennett RothLos Angeles$2.8M
- Douglas NguyenMission Viejo$2M
- Sammy SaabLos Angeles$1.9M
- Kenneth ChangNewport Beach$1.3M
- Joo HwangStanford$1M
- Drew SchembreWalnut Creek$659K
- Quan Nhula Jolla$641K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.